The RNZCGP has questioned the quantity of COVID-19 community antivirals on order by Pharmac, drugs which now seem unlikely to arrive until well into an Omicron wave
Pharmac has today confirmed the access criteria for two COVID-19 treatments – baricitinib and casirivimab with imdevimab (branded as Ronapreve). Both will be available for use in DHB hospitals from 1 February 2022
Pharmac has signed deals to supply 120,000 courses of antivirals to community patients, but with Omicron cases likely to surge ahead of Delta, the RNZCGP questions whether that is enough
One of the most important long-standing questions of public policy, and democratic governance, is about how corporate power operates, and what to do about it
Poverty targets are mostly on track nationally and for Pākehā children but, if they are to be met for Māori, Pacific and disabled children, much more focused efforts will be needed, says children’s commissioner Frances Eivers
Suzanne Pitama (Ngāti Kahungunu, Ngāti Whare) has been appointed dean and head of campus at the University of Otago, Christchurch. The former director of the Māori Indigenous Health Institute, and associate dean Māori at the campus, Professor Pitama is the first Māori female dean of any Otago Medical School campus
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management